EP3148545
ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.5.2015EP published:
15.3.2023EP application number:
15800211.3
EPO information:
European Patent Register
Max expiry date:
27.5.2035
Title in English:
ANTI-CANCER EFFECTS OF JAK2 INHIBITORS IN COMBINATION WITH THALIDOMIDE DERIVATIVES AND GLUCOCORTICOIDSLanguage of the patent:
English
Timeline
Today
28.5.2015EP application
15.3.2023EP Publication
Owner
Name:
Onco Tracker, Inc.Address:
9201 Sunset Boulevard, Suite 300, West Hollywood, CA 90069, US
Inventor
Name:
BERENSON, James R.Address:
West Hollywood, California 90069, US
Priority
Number:
201462004061 PDate:
28.5.2014Country:
US
Classification
Categories:
A61K 31/519, A61K 31/573, A61K 31/454, A61P 35/00, A61P 35/02, A61K 45/06